MX9605278A - Procedimiento para la inactivacion de virus en proteinas. - Google Patents

Procedimiento para la inactivacion de virus en proteinas.

Info

Publication number
MX9605278A
MX9605278A MX9605278A MX9605278A MX9605278A MX 9605278 A MX9605278 A MX 9605278A MX 9605278 A MX9605278 A MX 9605278A MX 9605278 A MX9605278 A MX 9605278A MX 9605278 A MX9605278 A MX 9605278A
Authority
MX
Mexico
Prior art keywords
proteins
virus inactivation
media
denaturalization
lipidic
Prior art date
Application number
MX9605278A
Other languages
English (en)
Inventor
D Pere Ristol Debart
Original Assignee
Grifols Grupo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Grupo Sa filed Critical Grifols Grupo Sa
Publication of MX9605278A publication Critical patent/MX9605278A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe un procedimiento industrial para inactivar virus en general (con y sin cubierta lipídica) de forma eficiente, en medios que contienen proteínas para uso terapéutico, sin que se produzca desnaturalizacion ni pérdida relevante de actividad biologica, mediante incubacion a pH extremo (álcali) en un medio estabilizado.
MX9605278A 1995-11-03 1996-10-31 Procedimiento para la inactivacion de virus en proteinas. MX9605278A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09502143A ES2099678B1 (es) 1995-11-03 1995-11-03 Procedimiento para la inactivacion de virus en proteinas.

Publications (1)

Publication Number Publication Date
MX9605278A true MX9605278A (es) 1997-05-31

Family

ID=8292048

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9605278A MX9605278A (es) 1995-11-03 1996-10-31 Procedimiento para la inactivacion de virus en proteinas.

Country Status (12)

Country Link
US (1) US5932468A (es)
EP (1) EP0771567B1 (es)
JP (1) JP3024073B2 (es)
AR (1) AR004224A1 (es)
AT (1) ATE211928T1 (es)
CZ (1) CZ292651B6 (es)
DE (1) DE69618536T2 (es)
ES (2) ES2099678B1 (es)
HU (1) HU221239B1 (es)
MX (1) MX9605278A (es)
SK (1) SK281404B6 (es)
UY (1) UY24358A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9900428D0 (en) * 1999-01-08 1999-02-24 Nat Blood Authority Virus inactivation process
JP5149470B2 (ja) 1999-02-22 2013-02-20 バクスター・インターナショナル・インコーポレイテッド 新規のアルブミンを含有していない第ｖｉｉｉ因子処方物
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
CN100457896C (zh) * 2005-10-26 2009-02-04 李法卿 灭活生物制品中病毒和去除细菌内毒素的方法
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
HUE061100T2 (hu) 2016-03-28 2023-05-28 Ultragenyx Pharmaceutical Inc Adenovírus hõinaktiválásának módszerei
KR101938304B1 (ko) 2016-05-13 2019-04-10 연세대학교 산학협력단 비대칭형 커프 구조를 갖는 구강 또는 비강 기관 삽관 튜브
WO2018119561A1 (zh) * 2016-12-26 2018-07-05 通博国际有限公司 可塌陷鼻腔喷射导管

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941696A (en) * 1973-12-20 1976-03-02 Baylor College Of Medicine Sterilization of holding tanks and toilet bowls by quaternary compounds
US4055655A (en) * 1975-07-21 1977-10-25 National Research Laboratories Complexes of heavy metal ions and polyfunctional organic ligands used as antimicrobial agents
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPH07121877B2 (ja) * 1986-05-31 1995-12-25 株式会社ミドリ十字 静注用非化学修飾免疫グロブリンの加熱処理方法
DE3816139A1 (de) * 1987-10-17 1989-04-27 Bayer Ag Verfahren zur herstellung von paramunitaetsinducern
DE3878227D1 (de) * 1988-05-27 1993-03-18 Centre Regional De Transfusion Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.
FR2695140B1 (fr) * 1992-08-06 1994-11-04 Aetsrn Procédé d'inactivation virale des produits plasmatiques par des fluides supercritiques ou subcritiques.
GB9306806D0 (en) * 1993-04-01 1993-05-26 Unilever Plc Disinfectant compositions
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins

Also Published As

Publication number Publication date
SK140796A3 (en) 1997-07-09
HUP9602914A2 (en) 1997-08-28
HU9602914D0 (en) 1996-12-30
DE69618536D1 (de) 2002-02-21
JP3024073B2 (ja) 2000-03-21
DE69618536T2 (de) 2002-09-12
SK281404B6 (sk) 2001-03-12
CZ292651B6 (cs) 2003-11-12
HU221239B1 (en) 2002-08-28
JPH09187273A (ja) 1997-07-22
HUP9602914A3 (en) 2000-03-28
CZ321596A3 (en) 1997-05-14
US5932468A (en) 1999-08-03
EP0771567A1 (en) 1997-05-07
ES2099678B1 (es) 1998-02-16
UY24358A1 (es) 1996-11-13
ES2170845T3 (es) 2002-08-16
ATE211928T1 (de) 2002-02-15
EP0771567B1 (en) 2002-01-16
AR004224A1 (es) 1998-11-04
ES2099678A1 (es) 1997-05-16

Similar Documents

Publication Publication Date Title
AU5817496A (en) Process for producing erythropoietin containing no animal pr oteins
RO117177B1 (ro) Proteine recombinante, anti-obezitate, murine şi umane, secvenţă adn, care le codifică, procedeu de producere a proteinei şi conjugat cu acestea
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
ES2170755T3 (es) Conjugados de farmaco antitumoral escindibles por enzimas lisosomales.
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
EP1136561A3 (en) Targeting gene therapy
IL123641A0 (en) Circular dna molecule with conditional origin of replication method for preparing the same and use thereof in gene therapy
DK0764209T3 (da) Albuminekspression i gær
EP1908773A3 (en) Process for producing dipeptides
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
DE59912185D1 (de) Verwendung von hsp70 protein
MX9605278A (es) Procedimiento para la inactivacion de virus en proteinas.
NO970325L (no) Fremgangsmåte for fremstilling av biologisk aktivt dimerisk protein
GEP20074226B (en) Novel selective inhibitors of viral or bacterial neuraminidases
GB2305936B (en) Sterile, disposable culture vessels for the rapid growth of bacteria
AU4876196A (en) A process for the preparation of factor ix from biological sources
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
AU3905893A (en) Plant resistant to two or more viruses and preparation thereof
ATE309371T1 (de) Protein mit dnase-aktivität
PL326631A1 (en) Compounds exhibiting haemoregulatory activity
DE60005643D1 (de) Pestizide verwendung von parasitären flagellaten zur eliminierung oder unterdrückung schädlicher algenblüte
BR9802715C1 (pt) Método de desnaturar produtos tóxicos e produtos tóxicos desnaturados obtidos
DE59611353D1 (de) Transketolase-verwandtes protein
MX9802979A (es) Procedimiento para la preparacion de moenomicina a.